Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility

• Published in: Diabetes (New York, N.Y.) Vol. 63; no. 7; pp. 2402 - 2414
• Main Authors: Kallionpää, Henna, Elo, Laura L., Laajala, Essi, Mykkänen, Juha, Ricaño-Ponce, Isis, Vaarma, Matti, Laajala, Teemu D., Hyöty, Heikki, Ilonen, Jorma, Veijola, Riitta, Simell, Tuula, Wijmenga, Cisca, Knip, Mikael, Lähdesmäki, Harri, Simell, Olli, Lahesmaa, Riitta
• Format: Journal Article
• Language: English
• Published: Alexandria, VA American Diabetes Association 01.07.2014
• Subjects: Adolescent; Autoantibodies - blood; Biological and medical sciences; Case-Control Studies; Child; Child, Preschool; Children & youth; Diabetes; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - genetics; Diabetes Mellitus, Type 1 - immunology; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Female; Genes; Genetic Predisposition to Disease; Genotype; HLA-DQ beta-Chains - genetics; Humans; Immunity, Innate - genetics; Interferon; Male; Medical sciences; Microarray Analysis; Pathogenesis; Ribonucleic acid; RNA; Transcriptome; Endocrinopathy; Human; Immunopathology; HLA-System; Sensitivity; Type 1 diabetes; Autoimmune disease; Child
• DOI: 10.2337/db13-1775
• ISSN: 0012-1797; 1939-327X

The insult leading to autoantibody development in children who will progress to develop type 1 diabetes (T1D) has remained elusive. To investigate the genes and molecular pathways in the pathogenesis of this disease, we performed genome-wide transcriptomics analysis on a unique series of prospective whole-blood RNA samples from at-risk children collected in the Finnish Type 1 Diabetes Prediction and Prevention study. We studied 28 autoantibody-positive children, out of which 22 progressed to clinical disease. Collectively, the samples covered the time span from before the development of autoantibodies (seroconversion) through the diagnosis of diabetes. Healthy control subjects matched for date and place of birth, sex, and HLA-DQB1 susceptibility were selected for each case. Additionally, we genotyped the study subjects with Immunochip to identify potential genetic variants associated with the observed transcriptional signatures. Genes and pathways related to innate immunity functions, such as the type 1 interferon (IFN) response, were active, and IFN response factors were identified as central mediators of the IFN-related transcriptional changes. Importantly, this signature was detected already before the T1D-associated autoantibodies were detected. Together, these data provide a unique resource for new hypotheses explaining T1D biology.